| Dr Willard Guy Andrews Iii, MD | |
|
1200 Old York Rd, Abington Cancer Care Specialists, Abington, PA 19001-3720 | |
| (215) 481-2400 | |
| (215) 481-7438 |
| Full Name | Dr Willard Guy Andrews Iii |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 44 Years |
| Location | 1200 Old York Rd, Abington, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508890104 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD033516E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thomas Jefferson University Hospital | Philadelphia, PA | Hospital |
| Abington Memorial Hospital | Abington, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
| Amh Medical Staff Service Fund | 9830003813 | 42 |
News Archive
Normally, male California mice are surprisingly doting fathers, but new research published in the journal Physiological and Biochemical Zoology suggests that high anxiety can turn these good dads bad.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
As the fall approaches, pediatric hospitals will start seeing children with seasonal influenza A and B. At the same time, COVID-19 will be co-circulating in communities with the flu and other respiratory viruses, making it more difficult to identify and prevent the novel coronavirus.
Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.
› Verified 6 days ago
| Entity Name | Amh Medical Staff Service Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356384457 PECOS PAC ID: 9830003813 Enrollment ID: O20031114000011 |
News Archive
Normally, male California mice are surprisingly doting fathers, but new research published in the journal Physiological and Biochemical Zoology suggests that high anxiety can turn these good dads bad.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
As the fall approaches, pediatric hospitals will start seeing children with seasonal influenza A and B. At the same time, COVID-19 will be co-circulating in communities with the flu and other respiratory viruses, making it more difficult to identify and prevent the novel coronavirus.
Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.
› Verified 6 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730122789 PECOS PAC ID: 3274437736 Enrollment ID: O20040325000316 |
News Archive
Normally, male California mice are surprisingly doting fathers, but new research published in the journal Physiological and Biochemical Zoology suggests that high anxiety can turn these good dads bad.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
As the fall approaches, pediatric hospitals will start seeing children with seasonal influenza A and B. At the same time, COVID-19 will be co-circulating in communities with the flu and other respiratory viruses, making it more difficult to identify and prevent the novel coronavirus.
Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Willard Guy Andrews Iii, MD 1200 Old York Rd, Abington Cancer Care Specialists, Abington, PA 19001-3720 Ph: (215) 481-2400 | Dr Willard Guy Andrews Iii, MD 1200 Old York Rd, Abington Cancer Care Specialists, Abington, PA 19001-3720 Ph: (215) 481-2400 |
News Archive
Normally, male California mice are surprisingly doting fathers, but new research published in the journal Physiological and Biochemical Zoology suggests that high anxiety can turn these good dads bad.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
As the fall approaches, pediatric hospitals will start seeing children with seasonal influenza A and B. At the same time, COVID-19 will be co-circulating in communities with the flu and other respiratory viruses, making it more difficult to identify and prevent the novel coronavirus.
Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.
› Verified 6 days ago
Dr. Shaili Nepal, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2191 Fax: 215-481-3411 | |
Muhammad Arslan Asghar Cheema, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2222 Fax: 215-481-4361 | |
Margaret Mack, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Joseph Guererri Crocetti Jr., DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Ste 121, Abington, PA 19001 Phone: 215-517-1200 Fax: 215-517-1219 | |
Dr. Joseph Mcallister, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Ste 113, Abington, PA 19001 Phone: 215-517-1180 | |
William L. Ward, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Suite 121, Abington, PA 19001 Phone: 215-517-1200 Fax: 215-517-1219 | |
Rebecca Jane Fallis, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd Ste 220, Abington, PA 19001 Phone: 215-481-6350 Fax: 215-481-4237 |